Clinical Trial Update: Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase III trial comparing vinflunine plus methotrexate to methotrexate alone in recurrent or metastatic head and neck carcinoma completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Or Metastatic Head and Neck Carcinoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Vinflunine (vinflunine)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Recurrent or Metastatic Head and Neck Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2019-02-04